scispace - formally typeset
O

Oxana Polyakova

Researcher at GlaxoSmithKline

Publications -  9
Citations -  582

Oxana Polyakova is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Netherton syndrome & LEKTI. The author has an hindex of 5, co-authored 8 publications receiving 446 citations.

Papers
More filters
Journal ArticleDOI

Discovery of Novel Irreversible Inhibitors of Interleukin (IL)-2-inducible Tyrosine Kinase (Itk) by Targeting Cysteine 442 in the ATP Pocket

TL;DR: This study confirms the irreversible covalent binding of the inhibitor to the kinase by x-ray crystallography and enzymology while demonstrating potency, selectivity, and prolonged duration of action in in vitro biological assays.
Journal ArticleDOI

Over expression of wild type or a catalytically dead mutant of Sirtuin 6 does not influence NFκB responses.

TL;DR: It is confirmed in cellular assays that SIRT6 can deacetylate acetylated-histone H3 lysine 9 (H3K9Ac), however this de acetylase activity is unusually low in biochemical assays.
Journal ArticleDOI

Identification of novel interacting partners of Sirtuin6.

TL;DR: A number of interacting partners are reported which strengthen previous findings that SIRT6 functions in base excision repair (BER), and novel interactors which suggest a role in nucleosome and chromatin remodeling, the cell cycle and NFκB biology.
Journal ArticleDOI

Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome.

TL;DR: X-ray crystallography was used to find alternatives to the phenol interaction leading to identification of carbonyl analogues such as lactam 13 and benzimidazole 15, which provided novel starting points for the guided growth towards suitable tool molecules for the exploration of KLK5 biology.